Terumo, Takeda To Co-promote Narcotic Formulations

Terumo and Takeda have announced that the two companies will initiate the co-promotion of ethical narcotic formulations in October, which is manufactured and marketed by Takeda in Japan.

Reportedly, ethical narcotic formulations are to be used for the patients with cancer as pain relievers.

Both the companies believe that the medical and scientific information on the relevant products can be shared with an even greater number of healthcare providers so that both companies can further contribute to the pain relieve treatment for patients with cancer.

Takeda is a research-based global pharmaceutical company. The company is enhancing its R&D pipeline by concentrating its management resources.